Dr. Peter Block and Dr. Anthony DeMaria discuss the cost-effectiveness analysis from MitraClip in heart failure and severe secondary mitral regurgitation (COAPT Cost-Effectiveness Analysis—0:25) and health status outcomes from transcatheter aortic valve replacement vs. surgical aortic valve replacement in severe aortic stenosis patients at low-surgical risk (PARTNER 3—2:55). Visit https://www.acc.org/TCT2019 for full meeting coverage. - Acute Coronary Syndromes - 107_5feba5631406a

Day 4 Highlights | TCT 2019

Day 4 Highlights | TCT 2019

12 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:


Dr. Peter Block and Dr. Anthony DeMaria discuss the cost-effectiveness analysis from MitraClip in heart failure and severe secondary mitral regurgitation (COAPT Cost-Effectiveness Analysis—0:25) and health status outcomes from transcatheter aortic valve replacement vs. surgical aortic valve replacement in severe aortic stenosis patients at low-surgical risk (PARTNER 3—2:55). Visit https://www.acc.org/TCT2019 for full meeting coverage.

Up Next Autoplay